… of functionalities, such as targeting, imaging and therapeutic features, onto their surfaces. …
affect the role of nanoparticles as imaging or therapeutic agents. We and others have …

… There has been a demand to develop ablative therapies that attempt to reduce treatment …
We reviewed the literature to concentrate on the practical aspects of focal therapy for Pca …

… pHLIP ® s target cancer cells in primary tumors as well as metastases based on the acidic
… Peptides of the pHLIP family share the same features in their primary sequences (Figure I) …

… with primary or metastatic liver cancer. In phase I/II clinical trials, they found that the
treatment efficacy was low. Detailed imaging analysis revealed retrospectively that PK2 targets …

… Because of the size and supramolecular structure of nanoparticle, technologies utilizing
nanoparticles have much potential for improving cancer therapy. A primary attribute of …

Successful development of safe and effective nanoprobes for targeted imaging and selective
therapy of in-situ gastric cancer is a great challenge. Herein, one kind of multifunctional …

Most hepatocellular carcinoma (HCC) therapies fail to target … imaging and simultaneously
monitoring targeted therapy in a … tumor model was applied for therapy by injecting 1.0 × 10 6 …

… In neuroendocrine tumors, NET can be targeted for imaging as well as therapy. One of the
most widely used theranostic agents targeting NET is metaiodobenzylguanidine (MIBG), a …

… This was a proof-of-principle evaluation of PSMA as a potential neovascular target. The
primary end points were targeting,toxicity, maximum-tolerated dose, pharmacokinetics (PK), and …

… A commonly held belief for all pretargeting procedures is that the primary targeting agent …
primary targeting agent than would be required to saturate the target antigen in most tumors. …